Sotirios Tsimikas Selected Research

Infarction (Infarctions)

1/2019	Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.
8/2008	Candidate biomarkers for the detection of coronary plaque destabilization and rupture.
6/2006	Successful utilization of a novel aspiration thrombectomy catheter (Pronto) for the treatment of patients with stent thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sotirios Tsimikas Research Topics

Disease

81	Cardiovascular Diseases (Cardiovascular Disease) 06/2024 - 04/2006
79	Atherosclerosis 01/2024 - 01/2002
30	Inflammation (Inflammations) 01/2024 - 07/2006
28	Aortic Valve Stenosis (Aortic Stenosis) 06/2023 - 02/2014
27	Coronary Artery Disease (Coronary Atherosclerosis) 03/2023 - 07/2005
26	Myocardial Infarction 01/2024 - 12/2006
20	Atherosclerotic Plaque (Atheroma) 01/2024 - 11/2002
19	Thrombosis (Thrombus) 01/2024 - 06/2002
18	Stroke (Strokes) 01/2024 - 11/2005
12	Coronary Disease (Coronary Heart Disease) 01/2024 - 07/2006
12	Acute Coronary Syndrome 08/2023 - 02/2003
11	Hypertriglyceridemia 04/2024 - 09/2011
10	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2020 - 05/2006
9	Hypercholesterolemia 01/2019 - 07/2005
8	Rupture 01/2021 - 01/2002
7	Peripheral Arterial Disease 10/2023 - 10/2007
6	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 04/2024 - 04/2016
6	Aortic Valve Disease 11/2023 - 01/2017
6	Pathologic Constriction (Stenosis) 01/2023 - 01/2004
5	Pancreatitis 04/2024 - 01/2019
5	Hypertension (High Blood Pressure) 01/2023 - 01/2007
5	Ischemic Stroke 01/2021 - 11/2005
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2011 - 04/2006
4	Transient Ischemic Attack 01/2024 - 08/2007
4	COVID-19 01/2024 - 01/2020
4	Obesity 08/2023 - 09/2011
4	Unstable Angina 01/2020 - 02/2012
3	Hemorrhage 11/2023 - 07/2012
3	Inborn Genetic Diseases (Disease, Hereditary) 05/2023 - 01/2010
3	Osteoporosis 01/2021 - 01/2018
3	Injection Site Reaction 01/2021 - 11/2016
3	Type 2 Diabetes Mellitus (MODY) 10/2020 - 01/2014
3	Necrosis 10/2019 - 11/2010
3	Infarction (Infarctions) 01/2019 - 06/2006
3	Neoplasms (Cancer) 11/2018 - 06/2012
3	Diabetes Mellitus 03/2018 - 09/2008
3	Stable Angina 05/2016 - 11/2005
2	Atrial Fibrillation 01/2024 - 02/2007

Drug/Important Bio-Agent (IBA)

89	Lipoprotein(a)IBA 06/2024 - 09/2004
53	Phospholipids (Phosphatides)FDA LinkGeneric 03/2024 - 09/2004
51	oxidized low density lipoproteinIBA 01/2024 - 01/2002
47	1-penicillamyl-Leu(2)- oxytocinIBA 01/2024 - 09/2004
41	Apolipoproteins B (ApoB)IBA 01/2024 - 06/2006
40	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2006
36	Lipoproteins (Lipoprotein)IBA 06/2024 - 07/2005
27	LipidsIBA 01/2024 - 01/2002
27	EpitopesIBA 01/2023 - 07/2008
25	Apolipoprotein B-100 (Apo B 100)IBA 01/2022 - 09/2004
20	ApolipoproteinsIBA 04/2024 - 06/2006
19	CholesterolIBA 08/2023 - 06/2002
18	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2023 - 06/2002
16	Triglycerides (Triacylglycerol)IBA 04/2024 - 09/2011
16	LDL Lipoproteins (beta Lipoproteins)IBA 01/2024 - 12/2004
16	AntibodiesIBA 01/2021 - 01/2002
14	Malondialdehyde (Propanedial)IBA 01/2023 - 12/2004
14	Immunoglobulin M (IgM)IBA 01/2023 - 06/2006
13	LDL CholesterolIBA 12/2023 - 04/2006
12	Apolipoproteins E (ApoE)IBA 01/2024 - 09/2006
11	Apolipoprotein C-IIIIBA 04/2024 - 10/2015
11	Apolipoproteins AIBA 01/2023 - 04/2005
10	AutoantibodiesIBA 01/2023 - 01/2006
9	LDL Receptors (LDL Receptor)IBA 03/2024 - 03/2003
9	Antisense OligonucleotidesIBA 05/2023 - 05/2014
8	ISIS 304801IBA 02/2024 - 04/2016
8	Atorvastatin (Lipitor)FDA Link 01/2017 - 09/2004
7	omega-Chloroacetophenone (Mace)IBA 01/2024 - 04/2015
7	Antigen-Antibody Complex (Immune Complex)IBA 11/2022 - 09/2004
7	Immunoglobulin G (IgG)IBA 11/2022 - 06/2006
7	AntigensIBA 07/2015 - 04/2009
6	Proteins (Proteins, Gene)FDA Link 03/2021 - 12/2006
6	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 08/2012 - 12/2006
5	PlasminogenIBA 01/2024 - 04/2012
5	EnzymesIBA 08/2023 - 12/2006
5	C-Reactive ProteinIBA 03/2023 - 04/2006
5	Proprotein Convertase 9IBA 11/2020 - 05/2014
5	Apoprotein(a) (Apolipoprotein (a))IBA 10/2020 - 04/2009
4	HDL CholesterolIBA 04/2024 - 01/2016
4	Prealbumin (Transthyretin)IBA 12/2023 - 10/2020
4	alirocumabIBA 08/2023 - 01/2020
4	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 04/2016
4	Messenger RNA (mRNA)IBA 05/2023 - 04/2016
4	AntioxidantsIBA 01/2017 - 01/2009
4	Phospholipases (Phospholipase)IBA 02/2014 - 02/2012
3	Scavenger Receptors (Scavenger Receptor)IBA 03/2024 - 04/2009
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 10/2022
3	Amyloid (Amyloid Fibrils)IBA 12/2023 - 01/2023
3	Single-Chain AntibodiesIBA 01/2019 - 10/2011
3	Rosuvastatin Calcium (Crestor)FDA Link 12/2018 - 09/2015
3	HDL LipoproteinsIBA 02/2017 - 09/2011
3	Secretory Phospholipases A2IBA 11/2013 - 02/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2013 - 06/2006
3	Matrix Metalloproteinases (MMPs)IBA 06/2012 - 08/2008
3	Pravastatin (Pravachol)FDA LinkGeneric 01/2011 - 05/2006
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2024 - 11/2023
2	Fibrinogen (Factor I)FDA Link 01/2024 - 09/2008
2	fibrin fragment D (D-dimer)IBA 01/2024 - 01/2018

Therapy/Procedure

32	Therapeutics 04/2024 - 01/2007
7	Percutaneous Coronary Intervention 05/2016 - 11/2005
6	Stents 01/2015 - 01/2004
4	Blood Component Removal (Apheresis) 01/2019 - 08/2012